Index
S&P 500
P/E
27.42
EPS (ttm)
5.97
Insider Own
3.55%
Shs Outstand
71.62M
Perf Week
4.04%
Market Cap
11.72B
Forward P/E
13.24
EPS next Y
12.36
Insider Trans
-0.31%
Shs Float
69.07M
Perf Month
-14.19%
Enterprise Value
10.77B
PEG
1.47
EPS next Q
2.64
Inst Own
101.00%
Perf Quarter
-9.74%
Income
429.89M
P/S
2.86
EPS this Y
8.24%
Inst Trans
-1.65%
Perf Half Y
22.39%
Sales
4.10B
P/B
2.82
EPS next Y
8.66%
ROA
6.92%
Perf YTD
4.78%
Book/sh
57.94
P/C
11.06
EPS next 5Y
9.00%
ROE
10.82%
52W High
208.30 -21.46%
Perf Year
-5.21%
Cash/sh
14.80
P/FCF
20.08
EPS past 3/5Y
7.03% -24.08%
ROIC
10.16%
52W Low
122.00 34.11%
Perf 3Y
-45.61%
Dividend Est.
-
EV/EBITDA
11.73
Sales past 3/5Y
2.61% 10.30%
Gross Margin
70.40%
Volatility
4.13% 3.71%
Perf 5Y
-72.35%
Dividend TTM
-
EV/Sales
2.63
EPS Y/Y TTM
8.65%
Oper. Margin
17.85%
ATR (14)
6.36
Perf 10Y
111.30%
Dividend Ex-Date
-
Quick Ratio
1.28
Sales Y/Y TTM
2.89%
Profit Margin
10.50%
RSI (14)
43.30
Dividend Gr. 3/5Y
- -
Current Ratio
1.39
EPS Q/Q
24.34%
SMA20
-2.64%
Beta
1.68
Payout
0.00%
Debt/Eq
0.03
Sales Q/Q
6.21%
SMA50
-6.09%
Rel Volume
0.73
Prev Close
163.04
Employees
20290
LT Debt/Eq
0.02
SMA200
3.89%
Avg Volume
1.15M
Price
163.61
IPO
Jan 26, 2001
Option/Short
Yes / Yes
Trades
Volume
844,543
Change
0.35%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-15-26 Initiated
Citigroup
Buy
$240
Mar-17-26 Upgrade
Barclays
Equal Weight → Overweight
$200
Feb-09-26 Upgrade
HSBC Securities
Hold → Buy
$200
Dec-09-25 Initiated
Barclays
Equal Weight
$170
Oct-10-25 Downgrade
Jefferies
Buy → Hold
$140
Jul-31-25 Downgrade
Morgan Stanley
Overweight → Equal-Weight
$154
Apr-25-25 Downgrade
HSBC Securities
Buy → Hold
$170
Feb-14-25 Initiated
Wells Fargo
Overweight
$255
Jan-06-25 Upgrade
Leerink Partners
Market Perform → Outperform
$235 → $280
Dec-04-24 Initiated
Mizuho
Outperform
$295
Oct-10-24 Initiated
Needham
Hold
Feb-26-24 Initiated
Leerink Partners
Market Perform
$310
Dec-11-23 Downgrade
Goldman
Neutral → Sell
$197
Oct-27-23 Downgrade
UBS
Buy → Neutral
$200
Feb-02-23 Upgrade
Goldman
Sell → Neutral
$165 → $307
Jul-28-22 Downgrade
Goldman
Buy → Sell
$380 → $250
Jan-31-22 Upgrade
UBS
Neutral → Buy
$880 → $620
Jan-31-22 Initiated
Morgan Stanley
Overweight
$575
Oct-01-21 Resumed
Credit Suisse
Outperform
$732
Aug-05-21 Resumed
Credit Suisse
Outperform
$732
Show Previous Ratings
May-22-26 04:10PM
May-21-26 04:40PM
May-20-26 04:01PM
May-01-26 05:55AM
Apr-30-26 02:55PM
03:17AM
Loading…
03:17AM
Apr-29-26 04:19PM
04:05PM
Apr-15-26 06:00PM
09:47AM
Apr-01-26 04:23PM
Mar-31-26 08:06PM
Mar-19-26 05:29PM
03:59PM
11:10AM
05:48AM
Loading…
05:48AM
Mar-17-26 04:36PM
11:17AM
10:15AM
09:33AM
08:19AM
07:59AM
06:35AM
Mar-11-26 04:33PM
Mar-10-26 10:55AM
Mar-06-26 11:30AM
09:38AM
08:22AM
Mar-05-26 07:02PM
08:52AM
08:30AM
Loading…
08:30AM
07:43AM
Mar-04-26 08:14AM
Mar-03-26 04:01PM
11:40AM
09:15AM
Mar-02-26 07:41AM
07:41AM
Feb-27-26 12:38PM
07:42AM
Feb-26-26 11:06PM
11:22AM
Feb-25-26 07:50AM
07:26AM
Feb-24-26 09:40AM
08:46AM
07:45AM
Feb-23-26 09:50AM
09:40AM
03:07AM
Feb-20-26 09:11AM
Feb-19-26 08:33AM
08:16AM
08:09AM
Feb-18-26 08:55AM
Feb-17-26 10:07AM
09:42AM
Feb-16-26 10:05AM
Feb-12-26 09:23AM
09:18AM
08:24AM
Feb-11-26 08:17AM
12:34AM
Feb-10-26 07:25PM
01:00PM
10:43AM
Feb-09-26 10:48AM
Feb-06-26 10:48AM
09:40AM
09:40AM
08:07AM
08:03AM
Feb-05-26 10:25AM
(Morningstar Research)
+8.88%
10:02AM
08:09AM
07:35AM
06:58AM
12:37AM
Feb-04-26 06:52PM
06:14PM
06:00PM
05:20PM
05:19PM
04:23PM
(Associated Press Finance)
04:06PM
Feb-03-26 09:15AM
09:15AM
08:29AM
Feb-02-26 10:16PM
05:00PM
Jan-30-26 09:20AM
Jan-29-26 10:00AM
09:55AM
08:02AM
Jan-28-26 10:00AM
Jan-23-26 03:58AM
Jan-22-26 09:09AM
Jan-21-26 07:09AM
Jan-13-26 11:01PM
05:00PM
Align Technology, Inc. is a medical device company, which engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner and Systems and Services segments. The Clear Aligner segment consists of invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Systems and Services segment includes sales related to iTero intraoral scanning systems, which includes a single hardware platform and restorative or orthodontic software options, upgrades and leases of scanner systems, sales of pre-owned scanner systems, subscription software, disposables, pay per scan services, as well as exocad's CAD/CAM software solutions that integrate workflows to dental labs and dental practices. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.
President Mr. Joseph M. Hogan
CFO & Executive VP of Global Finance Mr. John F. Morici
Executive VP and Chief Legal & Regulatory Officer Ms. Julie Ann Coletti J.D.
Executive VP & CTO Mr. Zelko Relic
Vice President of Corporate Communications & Investor Relations Ms. Shirley Stacy
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Vitalone Britt J. Director May 20 '26 Option Exercise 0.00 1,443 0 1,443 May 22 07:18 PM SIEGEL SUSAN E Director May 20 '26 Option Exercise 0.00 1,745 0 10,723 May 22 07:16 PM Saia Andrea Lynn Director May 20 '26 Option Exercise 0.00 1,745 0 17,318 May 22 07:15 PM Poul Mojdeh Director May 20 '26 Option Exercise 0.00 1,745 0 3,553 May 22 07:13 PM Myong Anne Director May 20 '26 Option Exercise 0.00 1,745 0 9,830 May 22 07:12 PM LARKIN C RAYMOND JR Director May 20 '26 Option Exercise 0.00 2,326 0 27,454 May 22 07:11 PM Dallas Kevin J Director May 20 '26 Option Exercise 0.00 1,745 0 16,168 May 22 07:10 PM LACOB JOSEPH Director May 20 '26 Option Exercise 0.00 1,745 0 135,916 May 22 07:08 PM Conroy Kevin T Director May 20 '26 Option Exercise 0.00 1,745 0 3,553 May 22 07:08 PM MORROW GEORGE J Director May 20 '26 Option Exercise 0.00 1,745 0 5,036 May 22 07:07 PM Morici John EVP, CHIEF FINANCIAL OFFICER Feb 20 '26 Option Exercise 0.00 7,848 0 16,085 Feb 24 08:01 PM Hockridge Stuart A EVP, GLOBAL HR Feb 20 '26 Option Exercise 0.00 4,310 0 16,102 Feb 24 08:00 PM Coletti Julie Ann EVP, CHIEF LEGAL & REGULATORY Feb 20 '26 Option Exercise 0.00 5,864 0 13,163 Feb 24 07:59 PM HOGAN JOSEPH M President and CEO Feb 20 '26 Option Exercise 0.00 40,248 0 225,377 Feb 24 07:56 PM Morici John EVP, CHIEF FINANCIAL OFFICER Feb 18 '26 Sale 189.31 7,969 1,508,646 8,237 Feb 20 07:59 PM John Morici Officer Feb 12 '26 Proposed Sale 185.95 7,969 1,481,836 Feb 12 04:43 PM HOGAN JOSEPH M PRESIDENT AND CEO Aug 01 '25 Buy 131.49 7,576 996,131 184,945 Aug 01 04:05 PM